e-learning
resources
Munich 2006
Monday 04.09.2006
Pulmonary hypertension: diagnostic tools and therapeutic approaches
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Assessment of pulmonary perfusion by MR in patients suffering from pulmonary arterial hypertension (PAH) in comparison to healthy volunteers
S. Ley, D. Mereles, C. Fink, F. Risse, E. Grünig, H. U. Kauczor (Heidelberg, Munich, Germany)
Source:
Annual Congress 2006 - Pulmonary hypertension: diagnostic tools and therapeutic approaches
Session:
Pulmonary hypertension: diagnostic tools and therapeutic approaches
Session type:
Thematic Poster Session
Number:
2483
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Ley, D. Mereles, C. Fink, F. Risse, E. Grünig, H. U. Kauczor (Heidelberg, Munich, Germany). Assessment of pulmonary perfusion by MR in patients suffering from pulmonary arterial hypertension (PAH) in comparison to healthy volunteers. Eur Respir J 2006; 28: Suppl. 50, 2483
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Analysis of flow vortices in the pulmonary artery of healthy volunteers and patients with pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology
Year: 2013
Quantitative estimation of lung perfusion scintigraphy in patients with chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation and functional lung imaging
Year: 2012
Screening for pulmonary vascular disease (PVD) in patients with portal hypertension by investigating pulmonary hemodynamics during exercise
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Quantitative estimation of lung perfusion scintigraphy in patients with idiopathic pulmonary arterial hypertension, receiving bosentan treatment
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013
Noninvasive estimation of PVR using contrast enhanced MRI in patients with idiopathic pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary circulation
Year: 2009
6MWD in patients with pulmonary arterial hypertension (PAH)
Source: Eur Respir J 2003; 22: Suppl. 45, 464s
Year: 2003
Effect of riociguat on pulmonary arterial compliance in patients with pulmonary arterial hypertension (PAH) in the RESPITE study
Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials
Year: 2017
Effect of riociguat on haemodynamic parameters and exercise capacity in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension
Year: 2009
Pulmonary arterial pressure response during exercise in COPD patients and healthy subjects
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009
The assessment of heart chambers volumes using modified transpulmonary thermodilution in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008
To study pulmonary hemodynamics and the prevalence of porto pulmonary hypertension (POPH) in cirrhotic patients
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
Comparison of activities of daily living in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and idiopathic pulmonary arterial hypertension (IPAH)
Source: International Congress 2016 – Best abstracts in exercise capacity and testing in chronic lung diseases
Year: 2016
Noninvasive assessment of pulmonary circulation in scleroderma patients
Source: Annual Congress 2005 - Exercise in pulmonary hypertension
Year: 2005
Exercise limitation in idiopathic pulmonary arterial hypertension (IPAH): there‘s more to it than just the pulmonary circulation
Source: Eur Respir J 2005; 26: Suppl. 49, 560s
Year: 2005
MRI-derived regional pulmonary perfusion and cardiac function for monitoring patients with chronic thromboembolic pulmonary hypertension before and after pulmonary endarterectomy
Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment
Year: 2015
Histopathology of idiopathic pulmonary arterial hypertension in patients with low or normal diffusion capacity
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012
Impact of pulmonary arterial hypertension (PAH) on the lives of patients and carers
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Patterns of mean pulmonary artery pressure (mPAP)-flow relation changes following chronic therapy in idiopathic pulmonary arterial hypertension (IPAH)
Source: Eur Respir J 2006; 28: Suppl. 50, 427s
Year: 2006
Plasma big-endothelin and hemodynamics in patients with pulmonary arterial hypertension compared to patients with chronic left heart failure with and without pulmonary venous hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Relationship between comorbidities and quality of life perceived by patients diagnosed with pulmonary hypertension: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept